Nephros (NASDAQ:NEPH) Shares Up 0.5%

Nephros, Inc. (NASDAQ:NEPHGet Free Report) shares traded up 0.5% on Tuesday . The stock traded as high as $2.28 and last traded at $2.20. 24,498 shares changed hands during trading, an increase of 30% from the average session volume of 18,888 shares. The stock had previously closed at $2.19.

Nephros Price Performance

The stock has a market cap of $23.19 million, a P/E ratio of -14.67 and a beta of 1.24. The stock’s fifty day simple moving average is $2.34 and its 200-day simple moving average is $2.67.

Nephros (NASDAQ:NEPHGet Free Report) last announced its quarterly earnings results on Thursday, March 7th. The company reported ($0.06) earnings per share (EPS) for the quarter. The company had revenue of $3.25 million during the quarter. Nephros had a negative return on equity of 18.25% and a negative net margin of 11.06%.

Institutional Trading of Nephros

A hedge fund recently bought a new stake in Nephros stock. Mesirow Financial Investment Management Inc. purchased a new position in Nephros, Inc. (NASDAQ:NEPHFree Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 15,383 shares of the company’s stock, valued at approximately $34,000. Mesirow Financial Investment Management Inc. owned approximately 0.15% of Nephros as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 41.10% of the company’s stock.

About Nephros

(Get Free Report)

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.

Further Reading

Receive News & Ratings for Nephros Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nephros and related companies with MarketBeat.com's FREE daily email newsletter.